Skip to Main Content

Paper Details

Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity.
bioRxiv
0
2023
Cancer, ER, ER-positive, ER-positive breast cancers, ER-positive cancer, Germline, HER2, HER2-positive breast cancer, Tumors, breast cancer, germline, germline genome, highly expressed, human, human epidermal growth factor receptor 2, polymorphic sites, recurrent amplicons, recurrently amplified genes, recurrently amplified regions, tumor, tumors
Author NameAffiliation
Kathleen E HoulahanStanford Cancer Institute, Stanford University School of Medicine
Michael AngeloStanford University School of Medicine
Christina CurtisStanford Cancer Institute, Stanford University School of Medicine
Christina CurtisStanford University School of Medicine
Christina CurtisStanford University School of Medicine
Christina CurtisStanford University School of Medicine
Christina Curtis
  • 1 - 7

Datasets

Release 1.2